Publication | Closed Access

No difference between alfacalcidol and paricalcitol in the treatment of secondary hyperparathyroidism in hemodialysis patients: a randomized crossover trial

HemodialysisUrologySecondary HyperparathyroidismHemodialysis PatientsRenal FunctionMedicineParathyroid HormoneParathyroid DiseaseRandomized Crossover TrialDialysis TherapyChronic Kidney DiseaseRenal PharmacologyNephrologyAnesthesiology